EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Transglutaminase 2 at the Interface of Gene Regulation and Antigen Processing in HLA-Restricted Immunity of Celiac Disease

Faustina Barbara Cannea, Alessandra Padiglia iD

Genes · 03.05.2026 · 17 (5) · 548

DOI: 10.3390/genes17050548 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 03.05.2026. Verfasst von Faustina Barbara Cannea und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Sciences (DiSVA), Biomedical Section, University of Cagliari, Cittadella Universitaria di Monserrato, Monserrato…. Hauptthemen laut MEDLINE: Celiac Disease, Transglutaminases, GTP-Binding Proteins, HLA-DQ Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Celiac disease (CD) is an immune-mediated enteropathy triggered by dietary gluten in genetically predisposed individuals. Although HLA-DQ2 and HLA-DQ8 are the primary genetic determinants of susceptibility, they are not sufficient to explain disease onset and progression. A key molecular event in CD pathogenesis is the post-translational modification of gluten peptides by transglutaminase 2 (TG2), which enhances their binding to HLA-DQ molecules and promotes CD4+ T cell activation. TG2 also acts as the principal autoantigen, driving the production of anti-TG2 autoantibodies through linked recognition mechanisms. Beyond its enzymatic activity, TG2 is tightly regulated by gene regulatory mechanisms, including cytokine-driven transcription, epigenetic modulation, and stress-responsive signaling pathways. These processes determine TG2 expression and activity in the intestinal mucosa, thereby influencing the efficiency of gluten peptide modification and antigen presentation. Here, we propose that TG2 operates at the interface between gene regulation and antigen processing, linking transcriptional control of TGM2 to HLA-restricted immune activation. In this framework, disease susceptibility arises from the coordinated interaction between HLA-dependent peptide presentation, TG2-mediated modification of gluten epitopes, and regulation of TG2 expression within the intestinal mucosa. This integrated model provides a mechanistic basis for disease heterogeneity and identifies TG2 as a central regulatory node and potential therapeutic target in CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseTransglutaminasesGTP-Binding ProteinsHLA-DQ AntigensAntigen PresentationHumansProtein Glutamine gamma Glutamyltransferase 2Gene Expression RegulationGlutens

Stichwörter der Autor:innen

HLA-DQ2HLA-DQ8TG2TGM2autoimmunityceliac diseasegene environment interactiongene regulationgluten deamidationtransglutaminase 2

Substanzen

Protein Glutamine gamma Glutamyltransferase 2TransglutaminasesGTP-Binding ProteinsHLA-DQ AntigensGlutensHLA-DQ2 antigenHLA-DQ8 antigen

Autor:innen und Institutionen

  • Department of Life and Environmental Sciences (DiSVA), Biomedical Section, University of Cagliari, Cittadella Universitaria di Monserrato, Monserrato, 09042 Cagliari, Italy.

ORCID-Profile: Alessandra Padiglia

Zitieren

APA

Cannea, F. B., & Padiglia, A. (2026). Transglutaminase 2 at the Interface of Gene Regulation and Antigen Processing in HLA-Restricted Immunity of Celiac Disease. Genes, 17(5), 548. https://doi.org/10.3390/genes17050548

Vancouver

Cannea FB, Padiglia A. Transglutaminase 2 at the Interface of Gene Regulation and Antigen Processing in HLA-Restricted Immunity of Celiac Disease. Genes. 2026;17(5):548. doi:10.3390/genes17050548

BibTeX
@article{Cannea2026,
  author = {Cannea, Faustina Barbara and Padiglia, Alessandra},
  title = {Transglutaminase 2 at the Interface of Gene Regulation and Antigen Processing in HLA-Restricted Immunity of Celiac Disease},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {548},
  doi = {10.3390/genes17050548}
}
Kostenlos starten →